New Two-Photon Activated Photodynamic Therapy Sensitizers Induce Xenograft Tumor Regressions after Near-IR Laser Treatment through the Body of the Host Mouse

Purpose: The aim of this study was to show that novel photodynamic therapy (PDT) sensitizers can be activated by two-photon absorption in the near-IR region of the spectrum and to show, for the first time, that such activation can lead to tumor regressions at significant tissue depth. These experiments also evaluated effects of high-energy femtosecond pulsed laser irradiation on normal tissues and characterized the response of xenograft tumors to our PDT protocols. Experimental Design: Human small cell lung cancer (NCI-H69), non-small cell lung cancer (A549), and breast cancer (MDA-MB-231) xenografts were induced in SCID mice. Irradiation of sensitized tumors was undertaken through the bodies of tumor-bearing mice to give a treatment depth of 2 cm. Posttreatment tumor regressions and histopathology were carried out to determine the nature of the response to these new PDT agents. Microarray expression profiles were conducted to assess the similarity of responses to single and two-photon activated PDT. Results: Regressions of all tumor types tested were seen. Histopathology was consistent with known PDT effects, and no, or minimal, changes were noted in irradiated normal tissues. Cluster analysis of microarray expression profiling showed reproducible changes in transcripts associated with apoptosis, stress, oxygen transport, and gene regulation. Conclusions: These new PDT sensitizers can be used at a depth of 2 cm to produce excellent xenograft regressions. The tumor response was consistent with known responses to single-photon activated PDT. Experiments in larger animals are warranted to determine the maximal achievable depth of treatment.

[1]  G. Mengod,et al.  Somatostatin receptor subtypes sst1, sst2, sst3 and sst5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: comparison of mRNA analysis with receptor autoradiography. , 1997, International journal of cancer.

[2]  H. Kato,et al.  Systemic Antitumor Effect of Intratumoral Injection of Dendritic Cells in Combination with Local Photodynamic Therapy , 2006, Clinical Cancer Research.

[3]  M. Copin,et al.  Endobronchial Phototoxicity of WST 09 (Tookad®), a New Fast-Acting Photosensitizer for Photodynamic Therapy: Preclinical Study in the Pig¶ , 2003, Photochemistry and photobiology.

[4]  F. Guillemin,et al.  Recent improvements in the use of synthetic peptides for a selective photodynamic therapy. , 2006, Anti-cancer agents in medicinal chemistry.

[5]  S. Awasthi,et al.  Therapeutic resistance in lung cancer , 2006, Expert opinion on drug metabolism & toxicology.

[6]  K. Moghissi,et al.  Photodynamic Therapy (PDT) in Esophageal Cancer: A Surgical View of its Indications Based on 14 Years Experience , 2003, Technology in cancer research & treatment.

[7]  J. Fuselier,et al.  Antitumor and antiangiogenic effects of somatostatin receptor-targeted in situ radiation with (111)In-DTPA-JIC 2DL. , 2001, The Journal of surgical research.

[8]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[9]  P. Frederiksen,et al.  Two-photon photosensitized production of singlet oxygen: optical and optoacoustic characterization of absolute two-photon absorption cross sections for standard sensitizers in different solvents. , 2006, The journal of physical chemistry. A.

[10]  J. Baatz,et al.  Hemoglobin Is Expressed by Alveolar Epithelial Cells* , 2006, Journal of Biological Chemistry.

[11]  C M Allen,et al.  Role of activated oxygen species in photodynamic therapy. , 2000, Methods in enzymology.

[12]  Hazel A. Collins,et al.  Determination of the triplet state energies of a series of conjugated porphyrin oligomers , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[13]  Eric G. Nickel,et al.  Efficient singlet oxygen generation upon two-photon excitation of new porphyrin with enhanced nonlinear absorption , 2001 .

[14]  G. Mengod,et al.  Somatostatin receptor subtypes sst1, sst2, sst3 and sst5expression in human pituitary, gastroentero‐pancreatic and mammary tumors , 1997 .

[15]  O. Puig,et al.  Foxo and Fos regulate the decision between cell death and survival in response to UV irradiation , 2007, The EMBO journal.

[16]  Luigi Corti,et al.  Long‐Term survival of patients treated with photodynamic therapy for carcinoma in situ and early non‐small‐cell lung carcinoma , 2007, Lasers in surgery and medicine.

[17]  Xiaohua Huang,et al.  Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. , 2006, Cancer letters.

[18]  Tayyaba Hasan,et al.  Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy. , 2005, International journal of radiation oncology, biology, physics.

[19]  H. Honda,et al.  Heat immunotherapy using magnetic nanoparticles and dendritic cells for T-lymphoma. , 2005, Journal of bioscience and bioengineering.

[20]  Prashant K. Jain,et al.  Determination of the Minimum Temperature Required for Selective Photothermal Destruction of Cancer Cells with the Use of Immunotargeted Gold Nanoparticles , 2006, Photochemistry and photobiology.

[21]  J. Bhawalkar,et al.  Two-photon photodynamic therapy. , 1997, Journal of clinical laser medicine & surgery.

[22]  R. Bashirzadeh,et al.  Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: Evidence for SSTR2 heterogeneity , 1994, Peptides.

[23]  W. Ahn,et al.  Photodynamic therapy‐generated tumor cell lysates with CpG‐oligodeoxynucleotide enhance immunotherapy efficacy in human papillomavirus 16 (E6/E7) immortalized tumor cells , 2007, Cancer science.

[24]  Maurice Aalders,et al.  Outcome of mTHPC Mediated Photodynamic Therapy is Primarily Determined by the Vascular Response , 2005, Photochemistry and photobiology.

[25]  T. Bekaii-Saab,et al.  Incorporation of photodynamic therapy as an induction modality in non‐small cell lung cancer , 2006, Lasers in surgery and medicine.

[26]  Paras N. Prasad,et al.  Photosensitization of Singlet Oxygen via Two-Photon-Excited Fluorescence Resonance Energy Transfer in a Water-Soluble Dendrimer , 2005 .

[27]  Zheng Huang,et al.  Preclinical Studies in Normal Canine Prostate of a Novel Palladium-Bacteriopheophorbide (WST09) Photosensitizer for Photodynamic Therapy of Prostate Cancer¶ , 2002, Photochemistry and photobiology.

[28]  M. Drobizhev,et al.  Photon energy upconversion in porphyrins: one-photon hot-band absorption versus two-photon absorption , 2003 .

[29]  D. Hoyer,et al.  [125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors. , 1998, European journal of pharmacology.

[30]  Paras N Prasad,et al.  Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy. , 2007, Journal of the American Chemical Society.

[31]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[32]  M. Calin,et al.  Photodynamic therapy in oncology , 2006 .

[33]  W.Phillip Helman,et al.  Quantum Yields for the Photosensitized Formation of the Lowest Electronically Excited Singlet State of Molecular Oxygen in Solution , 1993 .

[34]  Michael R Hamblin,et al.  Photodynamic therapy and anti-tumour immunity , 2006, Nature Reviews Cancer.

[35]  M. Korbelik,et al.  Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy , 2007, Cancer Immunology, Immunotherapy.

[36]  T. Nayak,et al.  A comparison of high- versus low-linear energy transfer somatostatin receptor targeted radionuclide therapy in vitro. , 2005, Cancer biotherapy & radiopharmaceuticals.

[37]  R. Cubeddu,et al.  Efficacy of photodynamic therapy against doxorubicin-resistant murine tumors. , 1995, Cancer letters.

[38]  M. J. Bragado,et al.  c-Jun N-terminal protein kinase signalling pathway mediates lovastatin-induced rat brain neuroblast apoptosis. , 2007, Biochimica et biophysica acta.

[39]  Allen Cm,et al.  Role of activated oxygen species in photodynamic therapy. , 2000 .

[40]  Avigdor Scherz,et al.  Photodynamic therapy with Pd‐bacteriopheophorbide (TOOKAD): Successful in vivo treatment of human prostatic small cell carcinoma xenografts , 2003, International journal of cancer.

[41]  Eric G. Nickel,et al.  Strong two-photon absorption in new asymmetrically substituted porphyrins: interference between charge-transfer and intermediate-resonance pathways. , 2006, The journal of physical chemistry. B.

[42]  Mamta Khurana,et al.  Simultaneous Two-photon Excitation of Photofrin in Relation to Photodynamic Therapy , 2006, Photochemistry and photobiology.

[43]  Tadeusz Martynkien,et al.  Modeling and measurement of temperature sensitivity in birefringent photonic crystal holey fibers. , 2005, Applied optics.

[44]  S. Gollnick,et al.  CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells , 2007, British Journal of Cancer.

[45]  B. Pogue,et al.  Vascular and cellular targeting for photodynamic therapy. , 2006, Critical reviews in eukaryotic gene expression.

[46]  Brian W. Pogue,et al.  Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[47]  E. Krenning,et al.  Somatostatin receptor imaging in vivo localization of tumors with a radiolabeled somatostatin analog , 1990, The Journal of Steroid Biochemistry and Molecular Biology.

[48]  C. Cullander.  Light microscopy of living tissue: the state and future of the art. , 1998, The journal of investigative dermatology. Symposium proceedings.

[49]  Aleksander Rebane,et al.  Blood-vessel closure using photosensitizers engineered for two-photon excitation , 2008 .

[50]  D. Apel,et al.  Palliation of Nonresectable Bile Duct Cancer: Improved Survival After Photodynamic Therapy , 2005, The American Journal of Gastroenterology.